Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study

BACKGROUND AND OBJECTIVES: Oral sodium zirconium cyclosilicate (formerly ZS-9) binds and removes potassium via the gastrointestinal tract. Sodium zirconium cyclosilicate–associated restoration and maintenance of normokalemia and adverse events were evaluated in a two-part, open label, phase 3 trial....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Spinowitz, Bruce S., Fishbane, Steven, Pergola, Pablo E., Roger, Simon D., Lerma, Edgar V., Butler, Javed, von Haehling, Stephan, Adler, Scott H., Zhao, June, Singh, Bhupinder, Lavin, Philip T., McCullough, Peter A., Kosiborod, Mikhail, Packham, David K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556727/
https://ncbi.nlm.nih.gov/pubmed/31110051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12651018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados